SCHEMBL13080337

SCHEMBL13080337

CCc1cn2ccc(OC)cc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METTL3 Q86U44 3/20 0.49
TP53 P04637 2/20 0.47
KDM4E B2RXH2 7/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPT P10636 4/20 0.44
PKM P14618 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
TLR9 Q9NR96 5/20 0.43
TLR7 Q9NYK1 4/20 0.43
TDP1 Q9NUW8 3/20 0.42
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529077 0.86 METTL3 (0.47) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL21835433 0.85 KDM4E (0.46) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL16449994 0.82 METTL3 (0.47) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL13080283 0.82 KDM4E (0.39) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL16442152 0.80 KDM4E (0.52) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL12329335 0.78 KDM4E (0.65) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL7975599 0.78 KDM4E (0.51) METTL3TP53KDM4EALDH1A1MAPT
SCHEMBL18026511 0.77 TLR9 (0.49) TP53KDM4EALDH1A1MAPTPKM
SCHEMBL22129495 0.77 TLR9 (0.52) METTL3TP53KDM4EPKMNPC1
SCHEMBL13080642 0.77 APP (0.49) METTL3TP53KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343973-B2 Phenoxymethyl heterocyclic compounds ENVIVO PHARMACEUTICALS, INC. (US) 2013-01-01 US disclosed
US-20100292238-A1 Phenoxymethyl Heterocyclic Compounds FMR LLC 2010-11-18 US disclosed
US-7714319-B2 Organic thin film transistor IDEMITSU KOSAN CO., LTD. (JP) 2010-05-11 US disclosed
US-20070120111-A1 Organic thin film transistor IDEMITSU KOSAN CO., LTD. (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292238-A1 Phenoxymethyl Heterocyclic Compounds PDE3A, PDE2A, PDE5A METTL3 3204/4885TP53 4831/4885KDM4E 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.